category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,10/64,63/2914,0.15873015873015872,7.2271825396825395,7.486883268886616,6.521425482011046e-7,1.0955994809778558e-4,8.306236666561439e-5,SELE/EDN1/CXCL2/CCL2/IRF1/IL1B/LIF/IL6/MLKL/SOCS3,10
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,13/64,127/2914,0.10236220472440945,4.660679133858268,6.320229361744089,2.186093589121974e-6,1.8363186148624583e-4,1.392196443598731e-4,IL4R/CXCL2/CSF3/CCL2/IL1R1/TNFRSF10B/IL1B/LIF/IL6/OSMR/IL7R/CXCL11/TNFRSF10D,13
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,9/64,59/2914,0.15254237288135594,6.945444915254238,6.912658598711755,3.544124920285963e-6,1.984709955360139e-4,1.504698650367023e-4,IL4R/CSF3/CISH/CDKN1A/LIF/IL6/OSMR/IL7R/SOCS3,9
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,8/64,49/2914,0.16326530612244897,7.433673469387754,6.805069129896819,7.688035372141697e-6,3.1077302933560597e-4,2.3561113126321006e-4,IL4R/CSF3/IL1R1/IL1B/IL6/IL7R/HLA-DRB5/ITGB3,8
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,9/64,66/2914,0.13636363636363635,6.2088068181818175,6.413247867381368,9.24919730165494e-6,3.1077302933560597e-4,2.3561113126321006e-4,SELE/EDN1/CCL2/IL1R1/IL1B/RAC2/THBD/CDH5/ITGB3,9
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,6/64,32/2914,0.1875,8.537109375,6.4234835729277195,5.131470186189844e-5,0.0014368116521331561,0.0010893120921560897,SELE/CSF3/CCL2/IL1B/IL6/THBS1,6
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,7/64,52/2914,0.1346153846153846,6.129206730769231,5.591841590259292,1.0851472544078973e-4,0.0025366988086718218,0.0019231864401584615,SELE/EDN1/CCL2/IL1B/IL6/THBD/COL4A1,7
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,6/64,37/2914,0.16216216216216217,7.3834459459459465,5.854959773304165,1.2079518136532486e-4,0.0025366988086718218,0.0019231864401584615,CXCL2/CCL2/TNFRSF10B/IL6/CXCL11/TNFRSF10D,6
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,7/64,55/2914,0.12727272727272726,5.794886363636363,5.378861792770312,1.5626990281418827e-4,0.0029170381858648477,0.0022115389754990386,GADD45B/CDK2/CDKN1A/IL6/PLK4/DEPP1/IL7R,7
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,12/64,171/2914,0.07017543859649122,3.195175438596491,4.432943392497002,2.547800351094285e-4,0.004280304589838399,0.003245093078762195,IL4R/FLT1/CSF3/VWF/CDK2/CDKN1A/IL6/THBS1/OSMR/IL7R/COL4A1/ITGB3,12
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,6/64,45/2914,0.13333333333333333,6.070833333333333,5.136391499743934,3.6884080080393087e-4,0.005633204957732763,0.00427078821983499,CXCL2/FLT1/CCL2/IL1B/IL6/HLA-DRB5,6
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,5/64,31/2914,0.16129032258064516,7.34375,5.320376721686896,4.772046873665378e-4,0.006680865623131528,0.005065067295732551,GADD45B/TNFRSF10B/CDK2/CDKN1A/THBS1,5
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,6/64,49/2914,0.12244897959183673,5.575255102040816,4.839370136586021,5.911965079316231e-4,0.007094358095179477,0.00537855469622003,EDN1/TIMP1/FLT1/CDKN1A/IL6/PDK1,6
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,6/64,49/2914,0.12244897959183673,5.575255102040816,4.839370136586021,5.911965079316231e-4,0.007094358095179477,0.00537855469622003,CCL2/IL1B/IL6/SOCS3/HLA-DRB5/ITGB3,6
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,5/64,35/2914,0.14285714285714285,6.504464285714286,4.90869498974382,8.520213205827458e-4,0.009542638790526753,0.007234707353720157,IL4R/IL1R1/IL1B/IL6/HLA-DRB5,5
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,3/64,10/2914,0.3,13.659374999999999,6.00830205979278,0.0010865023917232429,0.010929574461205453,0.0082862062017911,IL1B/IL6/HLA-DRB5,3
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,5/64,37/2914,0.13513513513513514,6.152871621621622,4.726264828913563,0.001105968844288647,0.010929574461205453,0.0082862062017911,CXCL2/CSF3/CCL2/IL1B/IL6,5
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,6/64,56/2914,0.10714285714285714,4.878348214285714,4.390838866847827,0.0012172785367467612,0.011361266342969772,0.00861349140037182,CCL2/TNFRSF10B/IL1B/IL6/SOCS3/HLA-DRB5,6
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,4/64,25/2914,0.16,7.285,4.728673351396483,0.0018934075985362708,0.016741709292320713,0.012692649275506304,IL4R/IL1B/IL6/HLA-DRB5,4
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,5/64,48/2914,0.10416666666666667,4.742838541666667,3.917611969452926,0.0036077716688288556,0.030305282018162388,0.02297580904885745,CXCL2/IL1R1/IL1B/IL6/COL4A1,5
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,7/64,95/2914,0.07368421052631578,3.3549342105263156,3.496478344863373,0.004261517958050607,0.034092143664404856,0.025846800647825737,CCL2/IL1R1/CDKN1A/IL1B/RAC2/IL6/ITGB3,7
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,6/64,78/2914,0.07692307692307693,3.5024038461538463,3.356521135960568,0.00660703621355419,0.04861638181958011,0.036858284462213,CXCL2/CCL2/IL1B/IL6/GBP2/CASP4,6
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,7/64,103/2914,0.06796116504854369,3.0943567961165046,3.2424751711552235,0.006655814177680611,0.04861638181958011,0.036858284462213,FLT1/VWF/RAC2/EMP1/THBS1/COL4A1/ITGB3,7
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,4/64,36/2914,0.1111111111111111,5.059027777777778,3.6716872235874005,0.007358715200410098,0.04922135363739417,0.03731694104088155,GADD45B/CDK2/CDKN1A/COL4A1,4
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,6/64,80/2914,0.075,3.4148437499999997,3.2814961968311427,0.007470139394318895,0.04922135363739417,0.03731694104088155,IL1R1/TNFRSF10B/IL1B/IL6/MYO1G/CASP4,6
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,3/64,19/2914,0.15789473684210525,7.189144736842104,4.055281017862352,0.00761759044388243,0.04922135363739417,0.03731694104088155,SELE/IL1B/IL6,3
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,6/64,85/2914,0.07058823529411765,3.213970588235294,3.103863655303859,0.00998256000480399,0.06211370669655816,0.0470912187361124,IL1R1/CDK2/CDKN1A/ZFP36/IL6/HLA-DRB5,6
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,4/64,40/2914,0.1,4.5531250000000005,3.3902747836199976,0.010693361122765383,0.0641601667365923,0.048642732926865086,TFPI/PLAUR/VWF/THBD,4
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,6/64,88/2914,0.06818181818181818,3.1044034090909087,3.003461389332312,0.011752425190234159,0.0680830148951496,0.05161682206963098,VWF/RAC2/FPR2/FPR1/CASP4/ITGB3,6
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,6/64,93/2914,0.06451612903225806,2.9375,2.8452435118965815,0.0151798616069448,0.08500722499889087,0.06444783348913406,SELE/CXCL2/CCL2/TNFRSF10B/IL1B/IL6,6
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,4/64,47/2914,0.0851063829787234,3.875,2.9772186497966775,0.01861732793815431,0.09473197775326034,0.07182060970015351,CXCL2/GADD45B/IL1R1/IL1B,4
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,5/64,71/2914,0.07042253521126761,3.2064260563380285,2.8201221613680785,0.01863984488644504,0.09473197775326034,0.07182060970015351,GADD45B/CDK2/CDKN1A/IL6/HLA-DRB5,5
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,2/64,10/2914,0.2,9.106250000000001,3.847330422883849,0.019076865034740653,0.09473197775326034,0.07182060970015351,IL1B/HLA-DRB5,2
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,6/64,98/2914,0.061224489795918366,2.787627551020408,2.697190065153624,0.019252030179245913,0.09473197775326034,0.07182060970015351,TNFRSF10B/IL1B/IL6/MLKL/ANXA2/CASP4,6
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,3/64,27/2914,0.1111111111111111,5.059027777777778,3.174814190754155,0.020299709518555784,0.09473197775326034,0.07182060970015351,IL1B/IL6/MLKL,3
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,3/64,27/2914,0.1111111111111111,5.059027777777778,3.174814190754155,0.020299709518555784,0.09473197775326034,0.07182060970015351,CXCL2/IL1B/IL6,3
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,2/64,11/2914,0.18181818181818182,8.278409090909092,3.6236570285230107,0.022989369674429622,0.10438416500822098,0.07913837071425277,IL1B/IL6,2
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,4/64,53/2914,0.07547169811320754,3.436320754716981,2.681953662969748,0.02772395166114619,0.12014462380291958,0.09108708947464456,GADD45B/CDK2/CDKN1A/IL6,4
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,5/64,79/2914,0.06329113924050633,2.881724683544304,2.540568418605148,0.028228867773002583,0.12014462380291958,0.09108708947464456,CXCL2/CLEC2B/CDKN1A/ZFP36/IL6,5
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,3/64,31/2914,0.0967741935483871,4.40625,2.8567540032703036,0.02932100938047442,0.12014462380291958,0.09108708947464456,CISH/IRF1/SOCS3,3
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,3/64,31/2914,0.0967741935483871,4.40625,2.8567540032703036,0.02932100938047442,0.12014462380291958,0.09108708947464456,GADD45B/CDKN1A/RAC2,3
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,5/64,84/2914,0.05952380952380952,2.710193452380952,2.3830297487898915,0.03557683308370664,0.14230733233482656,0.10788964418868431,CSF3/CCL2/VWF/IL1B/IL6,5
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,4/64,58/2914,0.06896551724137931,3.1400862068965516,2.4666297344029857,0.03704302006893666,0.1447262179437525,0.10972351109770712,VWF/THBS1/COL4A1/ITGB3,4
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,3/64,35/2914,0.08571428571428572,3.9026785714285714,2.588510529060366,0.04013722888514147,0.15325123756144926,0.11618671519383056,FPR2/FPR1/HLA-DRB5,3
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,2/64,15/2914,0.13333333333333333,6.070833333333333,2.9501130429570823,0.04148907239172615,0.15489253692911098,0.11743105869938864,GADD45B/CDKN1A,2
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,7/64,149/2914,0.04697986577181208,2.139052013422819,2.1385869962222634,0.042701098752785695,0.15595183892321732,0.11823416359466977,VWF/CDK2/CDKN1A/IRF1/THBS1/COL4A1/ITGB3,7
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,3/64,38/2914,0.07894736842105263,3.594572368421052,2.4121313069571046,0.049400898919457537,0.17658193656316737,0.13387477646706297,GADD45B/CDKN1A/RAC2,3
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,4/64,65/2914,0.06153846153846154,2.801923076923077,2.2013266952232184,0.05279700644351708,0.18478952255230977,0.14009731972950804,IL1R1/IL1B/SOCS3/ITGB3,4
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,4/64,66/2914,0.06060606060606061,2.7594696969696972,2.1663147963993423,0.05530571202810743,0.18961958409636834,0.14375920849411386,CCL2/IL1B/RAC2/IL6,4
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,2/64,18/2914,0.1111111111111111,5.059027777777778,2.588193823667102,0.057973251934701736,0.19479012650059782,0.14767923124418758,CDKN1A/THBS1,2
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,3/64,41/2914,0.07317073170731707,3.3315548780487805,2.252721773004372,0.05961786390730019,0.19638825757698886,0.14889084690987253,IL1B/IL6/SOCS3,3
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,3/64,42/2914,0.07142857142857142,3.252232142857143,2.2028421556474846,0.06322880766967194,0.20427768631740165,0.15487218072935843,IRF1/IL1B/IL6,3
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,3/64,45/2914,0.06666666666666667,3.0354166666666664,2.0617315099629514,0.07465492656477299,0.23664203137512949,0.17940905887462824,IL1B/IL6/CXCL11,3
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,3/64,46/2914,0.06521739130434782,2.969429347826087,2.0172863366467544,0.07865555301545608,0.24470616493697447,0.1855228443444481,IRF1/IL1B/IL6,3
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,4/64,75/2914,0.05333333333333334,2.4283333333333337,1.8776528737479705,0.08072908484236044,0.24659065915484643,0.18695156489809786,GADD45B/FLT1/CDKN1A/IL6,4
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,5/64,107/2914,0.04672897196261682,2.1276285046728973,1.7806334496390643,0.08370308658038789,0.25110925974116366,0.1903773209817093,FLT1/RAC2/THBS1/FPR1/ITGB3,5
Human Diseases,Cancer: overview,hsa05200,Pathways in cancer,9/64,249/2914,0.03614457831325301,1.645707831325301,1.59633824968351,0.09113376752234137,0.25970815946608355,0.19689653693857218,IL4R/EDN1/GADD45B/CDK2/CDKN1A/RAC2/IL6/IL7R/COL4A1,9
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,3/64,49/2914,0.061224489795918366,2.787627551020408,1.890821646619824,0.09120703219344602,0.25970815946608355,0.19689653693857218,HAMP/LRRC32/THBS1,3
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,3/64,49/2914,0.061224489795918366,2.787627551020408,1.890821646619824,0.09120703219344602,0.25970815946608355,0.19689653693857218,CCL2/IL1B/IL6,3
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,3/64,50/2914,0.06,2.731875,1.850771647416655,0.09556750348038484,0.26369680965561026,0.19992051358602034,GADD45B/CDK2/CDKN1A,3
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,3/64,51/2914,0.058823529411764705,2.6783088235294117,1.8116908510839573,0.1000129181893034,0.26369680965561026,0.19992051358602034,EDN1/IL6/ITGB3,3
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,2/64,25/2914,0.08,3.6425,1.9881494560167394,0.10316551639152219,0.26369680965561026,0.19992051358602034,CP/ACSL5,2
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,2/64,25/2914,0.08,3.6425,1.9881494560167394,0.10316551639152219,0.26369680965561026,0.19992051358602034,IL6/HLA-DRB5,2
Organismal Systems,Digestive system,hsa04978,Mineral absorption,2/64,25/2914,0.08,3.6425,1.9881494560167394,0.10316551639152219,0.26369680965561026,0.19992051358602034,MT1X/MT1A,2
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,4/64,82/2914,0.04878048780487805,2.221036585365854,1.6804545761859793,0.1038958020335651,0.26369680965561026,0.19992051358602034,CXCL2/CCL2/RAC2/CXCL11,4
Human Diseases,Infectious disease: viral,hsa05162,Measles,3/64,52/2914,0.057692307692307696,2.6268028846153846,1.7735342923060227,0.10454119702293654,0.26369680965561026,0.19992051358602034,CDK2/IL1B/IL6,3
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/64,5/2914,0.2,9.106250000000001,2.7181344460729693,0.10516479908884457,0.26369680965561026,0.19992051358602034,ACSL5,1
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,2/64,27/2914,0.07407407407407407,3.372685185185185,1.8558223812506467,0.11743028363763885,0.28183268073033324,0.21367014015269625,GADD45B/CDKN1A,2
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,2/64,27/2914,0.07407407407407407,3.372685185185185,1.8558223812506467,0.11743028363763885,0.28183268073033324,0.21367014015269625,GADD45B/CDKN1A,2
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,2/64,27/2914,0.07407407407407407,3.372685185185185,1.8558223812506467,0.11743028363763885,0.28183268073033324,0.21367014015269625,RAC2/HLA-DRB5,2
Metabolism,Metabolism of cofactors and vitamins,hsa00860,Porphyrin metabolism,1/64,6/2914,0.16666666666666666,7.588541666666666,2.420502414575227,0.12485178872731639,0.2913208403637383,0.22086354438604217,CP,1
Human Diseases,Immune disease,hsa05310,Asthma,1/64,6/2914,0.16666666666666666,7.588541666666666,2.420502414575227,0.12485178872731639,0.2913208403637383,0.22086354438604217,HLA-DRB5,1
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,3/64,57/2914,0.05263157894736842,2.396381578947368,1.5952333407459975,0.12835095903565272,0.2953830290135569,0.2239432738761929,CDK2/CDKN1A/SOCS3,3
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,2/64,29/2914,0.06896551724137931,3.1400862068965516,1.7353822755687438,0.1321604358864024,0.29866231823725,0.2264294517964113,SOCS3/ACSL5,2
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,3/64,58/2914,0.05172413793103448,2.3550646551724137,1.5618262291096445,0.13333139207020087,0.29866231823725,0.2264294517964113,TNFRSF10B/IL1B/MLKL,3
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,4/64,91/2914,0.04395604395604396,2.0013736263736264,1.4541165098499615,0.1376429045507084,0.30426326269103965,0.23067578186476065,PLAUR/CDKN1A/THBS1/ITGB3,4
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,2/64,30/2914,0.06666666666666667,3.0354166666666664,1.6790132560970004,0.13967929473249813,0.304754824870905,0.23104845745225255,ANGPTL4/ACSL5,2
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,2/64,31/2914,0.06451612903225806,2.9375,1.6249426440620074,0.14729021096367226,0.31322475242907516,0.2374698937588853,CDK2/CDKN1A,2
Human Diseases,Cancer: specific types,hsa05218,Melanoma,2/64,31/2914,0.06451612903225806,2.9375,1.6249426440620074,0.14729021096367226,0.31322475242907516,0.2374698937588853,GADD45B/CDKN1A,2
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,3/64,62/2914,0.04838709677419355,2.203125,1.4347282002460382,0.15390795448717254,0.31753166356543544,0.24073515846752938,CXCL2/IL1B/IL6,3
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,2/64,32/2914,0.0625,2.845703125,1.5729961068713902,0.15498569293074824,0.31753166356543544,0.24073515846752938,RAC2/CDH5,2
Human Diseases,Cancer: specific types,hsa05214,Glioma,2/64,32/2914,0.0625,2.845703125,1.5729961068713902,0.15498569293074824,0.31753166356543544,0.24073515846752938,GADD45B/CDKN1A,2
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,2/64,33/2914,0.06060606060606061,2.7594696969696972,1.523017633264694,0.16275852421624593,0.3214623354253882,0.24371517911323298,GADD45B/CDKN1A,2
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,2/64,33/2914,0.06060606060606061,2.7594696969696972,1.523017633264694,0.16275852421624593,0.3214623354253882,0.24371517911323298,SLC16A3/PDK1,2
Human Diseases,Immune disease,hsa05330,Allograft rejection,1/64,8/2914,0.125,5.69140625,1.990847664107428,0.16295534553037905,0.3214623354253882,0.24371517911323298,HLA-DRB5,1
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,3/64,64/2914,0.046875,2.13427734375,1.3747528028182971,0.16455810027728207,0.3214623354253882,0.24371517911323298,CDK2/CDKN1A/IL6,3
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,3/64,66/2914,0.045454545454545456,2.069602272727273,1.316928182202937,0.17542590385982995,0.3349039982778572,0.25390591348133285,THBS1/HLA-DRB5/ITGB3,3
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,3/64,66/2914,0.045454545454545456,2.069602272727273,1.316928182202937,0.17542590385982995,0.3349039982778572,0.25390591348133285,GADD45B/CDK2/CDKN1A,3
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,2/64,35/2914,0.05714285714285714,2.601785714285714,1.4284182987186393,0.17850869647801776,0.33696023604839304,0.2554648406131301,RAC2/IFITM1,2
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,2/64,36/2914,0.05555555555555555,2.529513888888889,1.383557076125107,0.18647290840227937,0.3480827623509215,0.2638973323587814,IL4R/HLA-DRB5,2
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,2/64,37/2914,0.05405405405405406,2.4611486486486487,1.3401799957417575,0.19448819628110336,0.35905513159588315,0.2722159832274552,GADD45B/CDKN1A,2
Genetic Information Processing,Translation,hsa03008,Ribosome biogenesis in eukaryotes,1/64,10/2914,0.1,4.5531250000000005,1.6863587859749174,0.19942469794992768,0.3641668397346505,0.2760914010519594,SNORD3B-1,1
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,2/64,39/2914,0.05128205128205128,2.3349358974358974,1.2575104131276873,0.2106483956155158,0.3805261340151253,0.2884941241593369,IL6/SOCS3,2
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,2/64,41/2914,0.04878048780487805,2.221036585365854,1.1797516444436102,0.2269443385733326,0.4056026476629774,0.3075057667119065,IL1B/HLA-DRB5,2
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,1/64,12/2914,0.08333333333333333,3.794270833333333,1.4532763827489363,0.23432886916199047,0.4143921054654147,0.31416945339169916,HLA-DRB5,1
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,5/64,155/2914,0.03225806451612903,1.46875,0.8986055134021468,0.25210607623087256,0.4409736669901475,0.3343221410138337,GADD45B/FLT1/IL1R1/IL1B/RAC2,5
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,3/64,80/2914,0.0375,1.7074218749999999,0.9613053400940148,0.2561511127930853,0.4409736669901475,0.3343221410138337,IL1B/IL6/HLA-DRB5,3
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,3/64,81/2914,0.037037037037037035,1.6863425925925926,0.9386376543505863,0.26214102121515576,0.4409736669901475,0.3343221410138337,IL1B/RAC2/IL6,3
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,3/64,81/2914,0.037037037037037035,1.6863425925925926,0.9386376543505863,0.26214102121515576,0.4409736669901475,0.3343221410138337,CDKN1A/THBS1/ITGB3,3
Cellular Processes,Cell motility,hsa04820,Cytoskeleton in muscle cells,4/64,119/2914,0.03361344537815126,1.5304621848739495,0.8852680767801895,0.2640806125024349,0.4409736669901475,0.3343221410138337,PDLIM1/THBS1/COL4A1/ITGB3,4
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,6/64,198/2914,0.030303030303030304,1.3797348484848486,0.8292509277086294,0.26608765929430483,0.4409736669901475,0.3343221410138337,EDN1/CHRNA10/ADM/FPR2/FPR1/S1PR3,6
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,1/64,14/2914,0.07142857142857142,3.252232142857143,1.2656568396962296,0.267734012101161,0.4409736669901475,0.3343221410138337,ACSL5,1
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,1/64,15/2914,0.06666666666666667,3.0354166666666664,1.1841661639149834,0.28389436493754905,0.46305100300493435,0.3510599709498563,IL7R,1
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,3/64,87/2914,0.034482758620689655,1.5700431034482758,0.8088020012621554,0.2984244078300863,0.47952564310338847,0.36355014295432336,IL1R1/IL1B/CASP4,3
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,1/64,16/2914,0.0625,2.845703125,1.1092014984220995,0.29970352693961777,0.47952564310338847,0.36355014295432336,ACSL5,1
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,3/64,88/2914,0.03409090909090909,1.5522017045454544,0.7881171887296229,0.30451243267294326,0.48262347819862705,0.3658987522683827,SELE/CDH5/HLA-DRB5,3
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,1/64,17/2914,0.058823529411764705,2.6783088235294117,1.0398241272201405,0.3151690115068585,0.4948448031135722,0.3751642930873574,HLA-DRB5,1
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,2/64,53/2914,0.03773584905660377,1.7181603773584906,0.790566205589824,0.3254629302586801,0.5062756692912802,0.38383055127973,RAC2/CDH5,2
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,2/64,54/2914,0.037037037037037035,1.6863425925925926,0.7627682608215521,0.3336023549238155,0.5141761066715689,0.38982023124849524,RAC2/S1PR3,2
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,2/64,55/2914,0.03636363636363636,1.655681818181818,0.735538157229167,0.3417155753454063,0.5218928787093479,0.3956706661894179,GADD45B/TNFRSF10B,2
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,2/64,56/2914,0.03571428571428571,1.6261160714285714,0.7088519724609009,0.3497998398742844,0.5294267846745927,0.40138246206532396,TNFRSF10B/RAC2,2
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,1/64,20/2914,0.05,2.2765625000000003,0.8583128535453497,0.35957618113202316,0.5345911365502646,0.40529779149487477,SOCS3,1
Human Diseases,Cancer: overview,hsa05204,Chemical carcinogenesis - DNA adducts,1/64,20/2914,0.05,2.2765625000000003,0.8583128535453497,0.35957618113202316,0.5345911365502646,0.40529779149487477,CYP3A43,1
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,2/64,59/2914,0.03389830508474576,1.5434322033898304,0.6318385498688873,0.37385330030726593,0.5509417057159708,0.4176938996969453,IL1R1/IL1B,2
Organismal Systems,Immune system,hsa04611,Platelet activation,2/64,61/2914,0.03278688524590164,1.492827868852459,0.5828369672216687,0.38969935516703225,0.5692999275483601,0.4316121004595964,VWF/ITGB3,2
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/64,23/2914,0.043478260869565216,1.9796195652173914,0.7067000496993916,0.40114591685814527,0.580969948553176,0.44045967277527753,ACSL5,1
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,2/64,65/2914,0.03076923076923077,1.4009615384615386,0.4898363030459349,0.4208621022725946,0.604314813519623,0.4581584739089874,EDN1/ADM,2
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,1/64,25/2914,0.04,1.82125,0.6178875083268673,0.42737138484465464,0.6049863296089323,0.45866758071855146,CDKN1A,1
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,2/64,66/2914,0.030303030303030304,1.3797348484848486,0.4675415680065319,0.4285319834729937,0.6049863296089323,0.45866758071855146,GADD45B/CDKN1A,2
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,2/64,68/2914,0.029411764705882353,1.3391544117647058,0.4240062698048158,0.4437156719063772,0.621201940668928,0.4709613710585232,CDK2/CDKN1A,2
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,2/64,69/2914,0.028985507246376812,1.3197463768115942,0.4027419247694394,0.45122666543689816,0.6230672958144361,0.4723755814132004,EDN1/COL4A1,2
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,1/64,27/2914,0.037037037037037035,1.6863425925925926,0.5368305717471383,0.4524655362461977,0.6230672958144361,0.4723755814132004,CDKN1A,1
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,2/64,70/2914,0.02857142857142857,1.300892857142857,0.38179822190237306,0.45868202341624964,0.6264122533798768,0.47491154548223746,CDK2/CDKN1A,2
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,1/64,28/2914,0.03571428571428571,1.6261160714285714,0.49879662147589465,0.46460346685937537,0.6264122533798768,0.47491154548223746,RAC2,1
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,2/64,71/2914,0.028169014084507043,1.2825704225352113,0.3611646574103943,0.46608054566955115,0.6264122533798768,0.47491154548223746,THBS1/ITGB3,2
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,1/64,29/2914,0.034482758620689655,1.5700431034482758,0.4622443221429332,0.47647643225126723,0.6353019096683563,0.4816511971796436,ANGPTL4,1
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,2/64,74/2914,0.02702702702702703,1.2305743243243243,0.3010269884264603,0.4879242429151811,0.6406182912261117,0.4856817872077664,GADD45B/CDKN1A,2
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,1/64,30/2914,0.03333333333333333,1.5177083333333332,0.4270571076152555,0.48809012664846607,0.6406182912261117,0.4856817872077664,RAC2,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/64,32/2914,0.03125,1.4228515625,0.360374240357308,0.5105618796736757,0.664917796784322,0.504104344679843,SOCS3,1
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,1/64,34/2914,0.029411764705882353,1.3391544117647058,0.2980426970335475,0.5320619157153268,0.6875877064628839,0.5212914315915348,CXCL2,1
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,1/64,35/2914,0.02857142857142857,1.300892857142857,0.2683260683769128,0.5424605398105418,0.6956745854058856,0.5274224613666175,IL6,1
Organismal Systems,Endocrine system,hsa04924,Renin secretion,1/64,36/2914,0.027777777777777776,1.2647569444444444,0.23949200239396012,0.552631614993635,0.7033493281737173,0.5332410320114022,EDN1,1
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/64,39/2914,0.02564102564102564,1.1674679487179487,0.1577549077693197,0.5818280498249492,0.7349406945157252,0.5571918799273357,SLC11A1,1
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,1/64,40/2914,0.025,1.1382812500000001,0.13194341176357507,0.5911369210636287,0.7356370573236268,0.5577198241613963,CDK2,1
Organismal Systems,Digestive system,hsa04976,Bile secretion,1/64,40/2914,0.025,1.1382812500000001,0.13194341176357507,0.5911369210636287,0.7356370573236268,0.5577198241613963,SLC4A5,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,1/64,43/2914,0.023255813953488372,1.0588662790697674,0.058266913829870315,0.6178567155506633,0.757058048839974,0.5739600495591282,CDK2,1
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,1/64,43/2914,0.023255813953488372,1.0588662790697674,0.058266913829870315,0.6178567155506633,0.757058048839974,0.5739600495591282,RAC2,1
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,1/64,44/2914,0.022727272727272728,1.0348011363636365,0.034851109965039984,0.6263754094568832,0.757058048839974,0.5739600495591282,CDKN1A,1
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,1/64,44/2914,0.022727272727272728,1.0348011363636365,0.034851109965039984,0.6263754094568832,0.757058048839974,0.5739600495591282,RAC2,1
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,1/64,46/2914,0.021739130434782608,0.9898097826086957,-0.010437838927113342,0.6428558511464644,0.7605618520606057,0.576616441725146,CDKN1A,1
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,1/64,46/2914,0.021739130434782608,0.9898097826086957,-0.010437838927113342,0.6428558511464644,0.7605618520606057,0.576616441725146,ITGB3,1
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,1/64,46/2914,0.021739130434782608,0.9898097826086957,-0.010437838927113342,0.6428558511464644,0.7605618520606057,0.576616441725146,HLA-DRB5,1
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,1/64,47/2914,0.02127659574468085,0.96875,-0.03236107228039864,0.650825595053935,0.7630910022810778,0.5785339052381605,ITGB3,1
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,2/64,101/2914,0.019801980198019802,0.9016089108910891,-0.15078890518526772,0.6582589113521733,0.7630910022810778,0.5785339052381605,RAC2/ITGB3,2
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",1/64,48/2914,0.020833333333333332,0.9485677083333333,-0.05383394426626919,0.6586202103021207,0.7630910022810778,0.5785339052381605,CDKN1A,1
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,1/64,50/2914,0.02,0.910625,-0.0955107706894918,0.6736991283466123,0.7752154353577456,0.5877259879591932,COL4A1,1
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,2/64,105/2914,0.01904761904761905,0.8672619047619048,-0.20756406169841027,0.6793390327481998,0.7763874659979426,0.5886145575548312,FLT1/RAC2,2
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,1/64,53/2914,0.018867924528301886,0.8590801886792453,-0.1551275231001378,0.6950961678293679,0.789028082400904,0.5981979822713622,EDN1,1
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,1/64,54/2914,0.018518518518518517,0.8431712962962963,-0.1742919044541658,0.701916805808718,0.7914229756769436,0.6000136595044498,ITGB3,1
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,1/64,55/2914,0.01818181818181818,0.827840909090909,-0.19312656987906196,0.708587198965446,0.7936176628412995,0.6016775514022384,HLA-DRB5,1
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,1/64,56/2914,0.017857142857142856,0.8130580357142857,-0.2116447511358305,0.7151106054943761,0.7956197465102992,0.6031954218530464,SOCS3,1
NA,NA,hsa04081,Hormone signaling,2/64,114/2914,0.017543859649122806,0.7987938596491228,-0.3283616577513722,0.7229733200876488,0.7978738272641639,0.6049043427253374,HAMP/ITGB3,2
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,1/64,59/2914,0.01694915254237288,0.7717161016949152,-0.26542145710866527,0.7338304528711763,0.7978738272641639,0.6049043427253374,RAC2,1
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,1/64,60/2914,0.016666666666666666,0.7588541666666666,-0.2827914029102813,0.7397971257315072,0.7978738272641639,0.6049043427253374,YBX3,1
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,2/64,119/2914,0.01680672268907563,0.7652310924369747,-0.39179686170370753,0.7450263537715633,0.7978738272641639,0.6049043427253374,EDN1/RAC2,2
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,1/64,61/2914,0.01639344262295082,0.7464139344262295,-0.29990051847684623,0.7456320885742485,0.7978738272641639,0.6049043427253374,ACSL5,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",1/64,61/2914,0.01639344262295082,0.7464139344262295,-0.29990051847684623,0.7456320885742485,0.7978738272641639,0.6049043427253374,SOCS3,1
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,2/64,121/2914,0.01652892561983471,0.7525826446280992,-0.41650975467068596,0.7534269397619944,0.799762702509783,0.6063363847348605,IL1B/IL6,2
NA,NA,hsa04382,Cornified envelope formation,1/64,63/2914,0.015873015873015872,0.722718253968254,-0.33337324735603147,0.7569182720181875,0.799762702509783,0.6063363847348605,COL4A1,1
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,1/64,65/2914,0.015384615384615385,0.7004807692307693,-0.36590889304270685,0.7677111743350775,0.8060967330518314,0.6111385006220026,LIF,1
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,1/64,80/2914,0.0125,0.5691406250000001,-0.5854885643974039,0.8349367147082944,0.8665037213396029,0.6569357787098493,RAC2,1
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,1/64,81/2914,0.012345679012345678,0.5621141975308641,-0.5988497682337917,0.8386643259498855,0.8665037213396029,0.6569357787098493,CDKN1A,1
Cellular Processes,Cell motility,hsa04814,Motor proteins,1/64,82/2914,0.012195121951219513,0.5552591463414634,-0.612075683648264,0.8423090429068949,0.8665037213396029,0.6569357787098493,MYO1G,1
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,1/64,83/2914,0.012048192771084338,0.5485692771084337,-0.6251698471664423,0.8458726803553266,0.8665037213396029,0.6569357787098493,RAC2,1
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,2/64,163/2914,0.012269938650306749,0.5586656441717791,-0.868868480599993,0.8823754669843723,0.8984186572931789,0.6811319394265332,IL1B/IL6,2
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,1/64,97/2914,0.010309278350515464,0.4693943298969072,-0.7963465987968814,0.888178387901212,0.8988793323337566,0.6814811980725849,RAC2,1
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,1/64,142/2914,0.007042253521126761,0.3206426056338028,-1.2436084528682736,0.9605714595529427,0.9663233844604452,0.7326135934819166,FLT1,1
Metabolism,Global and overview maps,hsa01100,Metabolic pathways,1/64,537/2914,0.00186219739292365,0.08478817504655493,-3.5182927554063808,0.9999981398821537,0.9999981398821537,0.7581439531688008,ACSL5,1
